Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis.
Safety of the use of anti-IL17A treatment in a patient with certolizumab-induced sarcoidosis.
Clin Exp Rheumatol. 2019 Mar 07;
Authors: Toussirot E, Bernard C, Bossert M
Abstract
PMID: 30873944 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Rheumatology - Category: Rheumatology Tags: Clin Exp Rheumatol Source Type: research
More News: Rheumatology | Sarcoidosis